California Biotech/Mass. General
Executive Summary
The Mountain View, Claif.-based biotech firm announced research and licensing agreements with Mass. General Hospital to develop compounds that regulate calcium metabolism by blocking the effects of parathyroid hormone. The compounds will be tested further for their use in a variety of conditions, including hypercalcemia associated with certain cancers.